Claudia Conte Selected Research

Claudia Conte Research Topics

Disease

19	Neoplasms (Cancer) 10/2022 - 07/2012
2	Breast Neoplasms (Breast Cancer) 03/2022 - 01/2020
2	Triple Negative Breast Neoplasms 09/2019 - 10/2014
2	Neoplasm Metastasis (Metastasis) 12/2018 - 10/2018
2	Glioblastoma (Glioblastoma Multiforme) 11/2015 - 04/2013
1	Lung Neoplasms (Lung Cancer) 07/2021
1	Communicable Diseases (Infectious Diseases) 10/2020
1	Chromosome Aberrations (Chromosome Abnormalities) 11/2015
1	Lung Diseases (Lung Disease) 01/2015
1	Cystic Fibrosis (Mucoviscidosis) 08/2014
1	Glioma (Gliomas) 04/2013

Drug/Important Bio-Agent (IBA)

10	Docetaxel (Taxotere)FDA Link 10/2022 - 07/2012
6	Pharmaceutical PreparationsIBA 01/2021 - 08/2014
4	Biological ProductsIBA 03/2022 - 02/2014
4	PolymersIBA 01/2021 - 03/2015
4	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2020 - 01/2016
3	Small Interfering RNA (siRNA)IBA 09/2021 - 11/2018
3	Hyaluronic Acid (Hyaluronan)IBA 01/2020 - 03/2015
2	LigandsIBA 10/2022 - 05/2016
2	LuciferasesIBA 07/2021 - 11/2018
2	AminesIBA 12/2018 - 10/2018
2	arecaidineIBA 11/2015 - 04/2013
2	Muscarinic M2 ReceptorIBA 11/2015 - 04/2013
1	AntioxidantsIBA 04/2022
1	Glutathione (Reduced Glutathione)IBA 04/2022
1	ElementsIBA 04/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2022
1	TubulinIBA 07/2021
1	DisulfidesIBA 07/2021
1	EmulsionsIBA 07/2021
1	polyethylene glycol-poly(lactide-co-glycolide)IBA 07/2021
1	Photosensitizing Agents (Photosensitizers)IBA 01/2020
1	ChlorineIBA 01/2020
1	chlorinIBA 10/2018
1	Proteins (Proteins, Gene)FDA Link 10/2018
1	Drug CarriersIBA 10/2018
1	Zn(II)-phthalocyanine (zinc phthalocyanine)IBA 10/2016
1	Antimitotic AgentsIBA 10/2016
1	Folic Acid (Vitamin M)FDA LinkGeneric 05/2016
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 05/2016
1	EnzymesIBA 11/2015
1	Histones (Histone)IBA 11/2015
1	Sirtuin 1IBA 11/2015
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 11/2015
1	Superoxide DismutaseIBA 11/2015
1	Cytostatic AgentsIBA 11/2015
1	EstersIBA 11/2015
1	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 04/2015
1	PolyethyleneimineIBA 04/2015
1	PorphyrinsIBA 03/2015
1	Drug CombinationsIBA 03/2015
1	polycaprolactoneIBA 10/2014
1	CyclodextrinsIBA 10/2014
1	PowdersIBA 10/2014
1	VaccinesIBA 10/2013
1	Neoplasm Antigens (Tumor Antigens)IBA 10/2013
1	Temozolomide (Temodar)FDA LinkGeneric 04/2013
1	polyethylene oxide-polycaprolactone copolymerIBA 07/2012

Therapy/Procedure

8	Therapeutics 01/2021 - 04/2013
5	Drug Therapy (Chemotherapy) 10/2022 - 02/2014
4	Photochemotherapy (Photodynamic Therapy) 01/2020 - 01/2016
1	Intravenous Injections 02/2014
1	Immunotherapy 10/2013